Navigation Links
China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
Date:9/21/2013

Dallas, TX (PRWEB) September 22, 2013

Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered on chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

Complete report is available at http://www.rnrmarketresearch.com/pharmapoint-non-small-cell-lung-cancer-china-drug-forecast-and-market-analysis-to-2022-market-report.html.

This report estimates that branded NSCLC market in China will grow in the forecast period. This increase will be due largely to an increasing aging population; increased use of EGFR and ALK targeted therapies and increased numbers of people covered by private health insurance.

Scope
Overview of NSCLC including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in China including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in China from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting China NSCLC market.

Reasons to Buy

  • Understand and Capitalize by Identifying Products That Are Most Likely to Ensure a Robust Return
  • Stay ahead of the competition by understanding the changing competitive landscape for NSCLC
  • Effectively Plan Your M&A and Partnership Strategies by Identifying Drugs With the Most Promising Sales Potential
  • Make More Informed Business Decisions from Insightful and In-Depth Analysis of Drug Performance
  • Obtain Sales Forecast for Drugs from 2012-2022 in China

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=114312.

Browse more reports on Respiratory Therapeutics Market http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics.

Contact sales (at) rnrmarketresearch (dot) com for further information.

About Us:

RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-non-small-cell-lung/drug-market-report/prweb11145242.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. China Human Rabies Vaccine Industry 2013 Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
2. 2013 China Medical Insurance Inflation Rates Revealed
3. China Poultry Vaccine Market Analysis
4. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at RnRMarketResearch.com
5. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
6. China Independent Clinical Laboratory Industry Report, 2013-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2015
7. Autonomous Clinical Laboratory Market in China 2013 Analysis & 2015 Forecasts in New Report Now Available at RnRMarketResearch.com
8. China BCAAs Market (Branched-Chain Amino Acids) Suppy & Forecasts in a New Research at ReportsnReports.com
9. Artisan Business Group Announces EB-5 China Trade Mission Itinerary
10. China Water and Air Pollution Impacts Food Supply Reports Water Advocate Sharon Kleyne
11. New risk model highlights arsenic risk in Chinas groundwater
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware of ... kids do not brush their teeth the minimum two times a day that dentists recommend. ... students missing 51 million hours of school and adults missing 164 million hours of work ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, ... app and centralized benefits dashboard solving one of the top frustrations in employee ... For the first time, employees can access up-to-date information and account balances for ...
(Date:3/23/2017)... Malvern, PA (PRWEB) , ... March 23, 2017 ... ... a comprehensive educational training program owned and organized by HMP Communications Holdings, LLC, ... training program for physicians within its nationwide network of wound centers interested in ...
(Date:3/23/2017)... Toronto,ON (PRWEB) , ... March 23, 2017 , ... ... launch of a new solution that enables organizations to easily reprint customer invoices, ... ‘PRO Reprint Server’ automates all of the steps needed to retrieve and print ...
(Date:3/23/2017)... ... ... prominently feature 150+ Hospital and Health System Executive Speakers including: , , ... President of the United States of America: George W. Bush , Boxing Legend, ... Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)...  The goal of the pilot is to ... prescription drugs as they are distributed in ... from US FDA to better protect consumers by improving ... Blockchain startup Chronicled, which links the physical ... technology and recently raised $6.25M, and the LinkLab, a ...
(Date:3/23/2017)... , March 23, 2017 Prima ... the TACTI-mel trial of IMP321 in combination with Keytruda, ... first (1mg/kg) cohort experiencing a complete response. Recruitment in ... is expected to be fully recruited by Q317. Preliminary ... AIPAC breast cancer study are expected mid-year (recruitment in ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 /PRNewswire/ ... the NASDAQ Composite ended the trading session at ... edged 0.03% lower, to finish at 20,661.30; and ... 0.19%. Gains were broad based as six out ... This Thursday, Stock-Callers.com has initiated reports coverage on ...
Breaking Medicine Technology: